Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1531846 | 0.96 | MEN1 (0.61) | KMT2AMEN1EPHX2LMNAALDH1A1 | |
| SCHEMBL1186911 | 0.89 | MEN1 (0.52) | KMT2AMEN1EPHX2LMNASMN1; SMN2 | |
| SCHEMBL8908122 | 0.87 | MEN1 (0.53) | KMT2AMEN1EPHX2 | |
| SCHEMBL11767308 | 0.87 | ELANE (0.52) | KMT2AMEN1LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL2281345 | 0.86 | SMN1; SMN2 (0.60) | KMT2AMEN1LMNASMN1; SMN2PARP10 | |
| SCHEMBL26452181 | 0.86 | PARP10 (0.58) | KMT2AMEN1LMNAALDH1A1SENP8 | |
| SCHEMBL3500438 | 0.85 | TNK2 (0.44) | KMT2AMEN1LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL220900 | 0.84 | KMT2A (0.51) | KMT2AMEN1 | |
| SCHEMBL6210554 | 0.84 | MEN1 (0.51) | KMT2AMEN1LMNASMN1; SMN2PARP10 | |
| SCHEMBL11768118 | 0.84 | MEN1 (0.48) | KMT2AMEN1LMNASMN1; SMN2PARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250164838-A1 | PHOTOALIGNMENT LAYER FOR LIQUID CRYSTAL DEVICES | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-05-22 | — | — | US | disclosed |
| CN-120010159-A | Photo-alignment layer for liquid crystal device | 香港科技大学 | 2025-05-16 | — | — | CN | disclosed |
| US-12234402-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2025-02-25 | — | — | US | disclosed |
| CN-113166649-B | Mesogenic compounds | 光学转变有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-113122269-B | Ultraviolet light absorber | 光学转变公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240019746-A1 | ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20240019746-A1 | ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20240019746-A1 | ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2024-01-18 | — | — | US | disclosed |
| US-20230383187-A1 | Mesogen Compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-11-30 | — | — | US | disclosed |
| US-11773326-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2023-10-03 | — | — | US | disclosed |
| US-6136969-A | PROTEIN KINASE INHIBITORS; 4-HYDROXYBENZOIC ACID 3-(4-(4-FLUOROBENZOYLOXY)-BENZOYLAMINO)-AZEPAN-4-YL ESTER | HOFFMANN-LA ROCHE INC. (US) | 2000-10-24 | — | — | US | disclosed |
| US-5907038-A | PROTEIN KINASE INHIBITORS | HOFFMANN-LA ROCHE INC. (US) | 1999-05-25 | — | — | US | disclosed |
| CN-1199396-A | Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases | HOFFMANN LA ROCHE (CH) | 1998-11-18 | — | — | CN | disclosed |
| EP-0836592-A1 | AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1998-04-22 | — | — | EP | disclosed |
| US-5661166-A | TREATING PEPTIC ULCERS | TOKYO TANABE CO. LTD. (JP) | 1997-08-26 | — | — | US | disclosed |
| US-5637254-A | ACRYLATED ESTERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-06-10 | — | — | US | disclosed |
| WO-1997002249-A1 | NOVEL AZEPANES AND THEIR RING HOMOLOGUES FOR THERAPY AND PROPHYLAXIS OF PROTEIN KINASE MEDIATED DISEASES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-01-23 | — | — | WO | disclosed |
| EP-0528699-B1 | Saishin N derivatives, process for their preparation and anti-ulcer agents containing them | TOKYO TANABE CO (JP) | 1996-11-06 | — | — | EP | disclosed |
| EP-0528699-A2 | Saishin N derivatives, process for their preparation and anti-ulcer agents containing them | TOKYO TANABE COMPANY LIMITED (JP) | 1993-02-24 | — | — | EP | disclosed |
| US-4824993-A | SYNTHETIC PROSTAGLANDINS, ANTISECRETORY AGENTS | GLAXO GROUP LIMITED (GB) | 1989-04-25 | — | — | US | disclosed |